High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells

Meredith C. Henderson, Irma M. Gonzales, Shilpi Arora, Ashish Choudhary, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses, David O. Azorsa

Research output: Contribution to journalArticle

Abstract

To identify novel targets in pancreatic cancer cells, we used high-throughput RNAi (HT-RNAi) to select genes that, when silenced, would decrease viability of pancreatic cancer cells. The HT-RNAi screen involved reverse transfecting the pancreatic cancer cell line BxPC3 with a siRNA library targeting 572 kinases. From replicate screens, approximately 32 kinases were designated as hits, of which 22 kinase targets were selected for confirmation and validation. One kinase identified as a hit from this screen was tyrosine kinase nonreceptor 1 (TNK1), a kinase previously identified as having tumor suppressor-like properties in embryonic stem cells. Silencing of TNK1 with siRNA showed reduced proliferation in a panel of pancreatic cancer cell lines. Furthermore, we showed that silencing of TNK1 led to increased apoptosis through a caspase-dependent pathway and that targeting TNK1 with siRNA can synergize with gemcitabine treatment. Despite previous reports that TNK1 affects Ras and NF-κB signaling, we did not find similar correlations with these pathways in pancreatic cancer cells. Our results suggest that TNK1 in pancreatic cancer cells does not possess the same tumor suppressor properties seen in embryonic cells but seems to be involved in growth and survival. The application of functional genomics by using HT-RNAi screens has allowed us to identify TNK1 as a growth-associated kinase in pancreatic cancer cells.

Original languageEnglish (US)
Pages (from-to)724-732
Number of pages9
JournalMolecular Cancer Research
Volume9
Issue number6
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

RNA Interference
Pancreatic Neoplasms
Protein-Tyrosine Kinases
Phosphotransferases
Growth
Small Interfering RNA
gemcitabine
Cell Line
Embryonic Stem Cells
Caspases
Genomics
Neoplasms
Apoptosis
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Henderson, M. C., Gonzales, I. M., Arora, S., Choudhary, A., Trent, J. M., Von Hoff, D. D., ... Azorsa, D. O. (2011). High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. Molecular Cancer Research, 9(6), 724-732. https://doi.org/10.1158/1541-7786.MCR-10-0436

High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. / Henderson, Meredith C.; Gonzales, Irma M.; Arora, Shilpi; Choudhary, Ashish; Trent, Jeffrey M.; Von Hoff, Daniel D.; Mousses, Spyro; Azorsa, David O.

In: Molecular Cancer Research, Vol. 9, No. 6, 06.2011, p. 724-732.

Research output: Contribution to journalArticle

Henderson, MC, Gonzales, IM, Arora, S, Choudhary, A, Trent, JM, Von Hoff, DD, Mousses, S & Azorsa, DO 2011, 'High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells', Molecular Cancer Research, vol. 9, no. 6, pp. 724-732. https://doi.org/10.1158/1541-7786.MCR-10-0436
Henderson, Meredith C. ; Gonzales, Irma M. ; Arora, Shilpi ; Choudhary, Ashish ; Trent, Jeffrey M. ; Von Hoff, Daniel D. ; Mousses, Spyro ; Azorsa, David O. / High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. In: Molecular Cancer Research. 2011 ; Vol. 9, No. 6. pp. 724-732.
@article{c10c93710d794205b6004f59b9a6f748,
title = "High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells",
abstract = "To identify novel targets in pancreatic cancer cells, we used high-throughput RNAi (HT-RNAi) to select genes that, when silenced, would decrease viability of pancreatic cancer cells. The HT-RNAi screen involved reverse transfecting the pancreatic cancer cell line BxPC3 with a siRNA library targeting 572 kinases. From replicate screens, approximately 32 kinases were designated as hits, of which 22 kinase targets were selected for confirmation and validation. One kinase identified as a hit from this screen was tyrosine kinase nonreceptor 1 (TNK1), a kinase previously identified as having tumor suppressor-like properties in embryonic stem cells. Silencing of TNK1 with siRNA showed reduced proliferation in a panel of pancreatic cancer cell lines. Furthermore, we showed that silencing of TNK1 led to increased apoptosis through a caspase-dependent pathway and that targeting TNK1 with siRNA can synergize with gemcitabine treatment. Despite previous reports that TNK1 affects Ras and NF-κB signaling, we did not find similar correlations with these pathways in pancreatic cancer cells. Our results suggest that TNK1 in pancreatic cancer cells does not possess the same tumor suppressor properties seen in embryonic cells but seems to be involved in growth and survival. The application of functional genomics by using HT-RNAi screens has allowed us to identify TNK1 as a growth-associated kinase in pancreatic cancer cells.",
author = "Henderson, {Meredith C.} and Gonzales, {Irma M.} and Shilpi Arora and Ashish Choudhary and Trent, {Jeffrey M.} and {Von Hoff}, {Daniel D.} and Spyro Mousses and Azorsa, {David O.}",
year = "2011",
month = "6",
doi = "10.1158/1541-7786.MCR-10-0436",
language = "English (US)",
volume = "9",
pages = "724--732",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells

AU - Henderson, Meredith C.

AU - Gonzales, Irma M.

AU - Arora, Shilpi

AU - Choudhary, Ashish

AU - Trent, Jeffrey M.

AU - Von Hoff, Daniel D.

AU - Mousses, Spyro

AU - Azorsa, David O.

PY - 2011/6

Y1 - 2011/6

N2 - To identify novel targets in pancreatic cancer cells, we used high-throughput RNAi (HT-RNAi) to select genes that, when silenced, would decrease viability of pancreatic cancer cells. The HT-RNAi screen involved reverse transfecting the pancreatic cancer cell line BxPC3 with a siRNA library targeting 572 kinases. From replicate screens, approximately 32 kinases were designated as hits, of which 22 kinase targets were selected for confirmation and validation. One kinase identified as a hit from this screen was tyrosine kinase nonreceptor 1 (TNK1), a kinase previously identified as having tumor suppressor-like properties in embryonic stem cells. Silencing of TNK1 with siRNA showed reduced proliferation in a panel of pancreatic cancer cell lines. Furthermore, we showed that silencing of TNK1 led to increased apoptosis through a caspase-dependent pathway and that targeting TNK1 with siRNA can synergize with gemcitabine treatment. Despite previous reports that TNK1 affects Ras and NF-κB signaling, we did not find similar correlations with these pathways in pancreatic cancer cells. Our results suggest that TNK1 in pancreatic cancer cells does not possess the same tumor suppressor properties seen in embryonic cells but seems to be involved in growth and survival. The application of functional genomics by using HT-RNAi screens has allowed us to identify TNK1 as a growth-associated kinase in pancreatic cancer cells.

AB - To identify novel targets in pancreatic cancer cells, we used high-throughput RNAi (HT-RNAi) to select genes that, when silenced, would decrease viability of pancreatic cancer cells. The HT-RNAi screen involved reverse transfecting the pancreatic cancer cell line BxPC3 with a siRNA library targeting 572 kinases. From replicate screens, approximately 32 kinases were designated as hits, of which 22 kinase targets were selected for confirmation and validation. One kinase identified as a hit from this screen was tyrosine kinase nonreceptor 1 (TNK1), a kinase previously identified as having tumor suppressor-like properties in embryonic stem cells. Silencing of TNK1 with siRNA showed reduced proliferation in a panel of pancreatic cancer cell lines. Furthermore, we showed that silencing of TNK1 led to increased apoptosis through a caspase-dependent pathway and that targeting TNK1 with siRNA can synergize with gemcitabine treatment. Despite previous reports that TNK1 affects Ras and NF-κB signaling, we did not find similar correlations with these pathways in pancreatic cancer cells. Our results suggest that TNK1 in pancreatic cancer cells does not possess the same tumor suppressor properties seen in embryonic cells but seems to be involved in growth and survival. The application of functional genomics by using HT-RNAi screens has allowed us to identify TNK1 as a growth-associated kinase in pancreatic cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=79959228539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959228539&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-10-0436

DO - 10.1158/1541-7786.MCR-10-0436

M3 - Article

C2 - 21536687

AN - SCOPUS:79959228539

VL - 9

SP - 724

EP - 732

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 6

ER -